The 21-aminosteroid U74389G enhances hepatic blood flow and preserves sinusoidal endothelial cell function and structure in endotoxin-shocked dogs.

BACKGROUND 21-Aminosteroids are potent anti-inflammatory and antioxidant drugs that provide remarkable endothelial protection in different models of tissue ischemia-reperfusion and inflammation. The effects of 21-aminosteroids in sepsis, a highly inflammatory condition leading to panendothelial activation and injury, are largely uninvestigated. We therefore explored the effects of the 21-aminosteroid U74386G on hepatic blood flow, endothelial cell function, and sinusoidal structure in a canine model of fluid-resuscitated, hyperdynamic endotoxic shock. MATERIALS AND METHODS Following invasive hemodynamic monitoring and placement of ultrasonic flow probes around the common hepatic artery and the portal vein, 12 anesthetized dogs received 2 mg/kg iv of Escherichia coli endotoxin, followed by generous saline infusion, before randomization into two groups. One group (N = 6) received U74389G as an iv bolus of 80 microg/kg, followed by a continuous infusion of 10 microg/kg. min. The other group (N = 6) received an equivalent volume of vehicle. Hyaluronic acid was measured in plasma for in vivo evaluation of endothelial cell function. Liver biopsies were taken after 4 h of endotoxic shock and prepared for light and electron microscopic examination. RESULTS Compared with the vehicle-treated controls, U74389G maintained a higher blood flow in the hepatic artery and in the portal vein, without markedly influencing the systemic hemodynamic response. The endotoxin-induced increase in plasma hyaluronic acid levels was significantly attenuated following U74389G treatment (70 +/- 14 vs 188 +/- 24 ng/mL after 3 h of endotoxic shock; P < 0.05). Morphological studies showed that the U74389G-treated group had less sinusoidal endothelial cell damage together with a dramatic reduction of neutrophil infiltration into the liver tissue. CONCLUSION U74389G can preserve the functional and structural integrity of endothelial cells in the hepatic sinusoid during hyperdynamic endotoxic shock. This endothelial-protective effect was associated with a better maintained hepatic blood flow and a significant attenuation of inflammatory liver injury.

[1]  M. Weber,et al.  Inhibition of tumor necrosis factor-alpha release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G. , 1999, Critical care medicine.

[2]  J. Vincent,et al.  Intrahepatocellular erythrocyte inclusions and increased calcium precipitation in canine endotoxic shock. , 1997, Journal of hepatology.

[3]  J. Vincent,et al.  POTENTIAL THERAPEUTIC VALUE OF LAZAROIDS IN ENDOTOXEMIA AND OTHER FORMS OF SEPSIS , 1997, Shock.

[4]  J. Vincent,et al.  Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. , 1996, American journal of respiratory and critical care medicine.

[5]  H. Jaeschke,et al.  Sinusoidal endothelial cell and parenchymal cell injury during endotoxemia and hepatic ischemia-reperfusion: protection by the 21-aminosteroid tirilazad mesylate , 1997 .

[6]  Y. Shibayama,et al.  Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo. , 2008, Liver.

[7]  L. Toledo-Pereyra,et al.  21-Aminosteroids block neutrophil infiltration and provide liver protection independent of NO2-/NO3- levels. , 1996, The Journal of surgical research.

[8]  M. Davies,et al.  Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. , 1996, Critical care medicine.

[9]  M. Portolés,et al.  Comparative in vivo and in vitro models to approach the cellular basis of endotoxic shock. The role of sinusoidal liver cells. , 1996, Histology and histopathology.

[10]  H. Jaeschke,et al.  The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation. , 1996, The Journal of pharmacology and experimental therapeutics.

[11]  H. Jaeschke,et al.  Neutrophil-induced lung damage after hepatic ischemia and endotoxemia. , 1996, Free radical biology & medicine.

[12]  T. Billiar,et al.  Liver injury during sepsis. , 1995, Journal of critical care.

[13]  A. Webb,et al.  Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. , 1995, Critical care medicine.

[14]  D. Altavilla,et al.  Improved survival and reversal of endothelial dysfunction by the 21‐aminosteroid, U‐74389G in splanchnic ischaemia‐reperfusion injury in the rat , 1995, British journal of pharmacology.

[15]  J. Vincent,et al.  Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs. , 1995, The American journal of physiology.

[16]  E. S. Fox,et al.  Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. , 1994, The American journal of physiology.

[17]  H. Jaeschke,et al.  The 21-aminosteroid tirilazad mesylate protects against endotoxin shock and acute liver failure in rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[18]  J. Spitzer,et al.  Gram‐negative bacterial lipopolysaccharide impairs hyaluronan clearance in vivo and its uptake by the isolated, perfused rat liver , 1993, Hepatology.

[19]  Hall Ed,et al.  Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock. , 1993 .

[20]  F. Doi,et al.  Potential role of hepatic macrophages in neutrophil‐mediated liver injury in rats with sepsis , 1993, Hepatology.

[21]  M. Poznansky,et al.  Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). , 1993, Biochemical pharmacology.

[22]  A. M. Lefer,et al.  Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals. , 1992, European journal of pharmacology.

[23]  R. Bone,et al.  The pathogenesis of sepsis. , 1991, Annals of internal medicine.

[24]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[25]  K. Audus,et al.  Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. , 1991, Free radical biology & medicine.

[26]  P. Schumacker,et al.  Endotoxin in vivo impairs endothelium-dependent relaxation of canine arteries in vitro. , 1990, The American review of respiratory disease.

[27]  D. Herndon,et al.  Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). , 1990, The Journal of trauma.

[28]  M. Pinsky,et al.  Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. , 1990, The American review of respiratory disease.

[29]  R. Wilson,et al.  Hepatic parenchymal oxygen tension following injury and sepsis. , 1990, Archives of surgery.

[30]  A. M. Lefer,et al.  Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. , 1989, The American journal of physiology.

[31]  P. Southorn,et al.  Free radicals in medicine. I. Chemical nature and biologic reactions. , 1988, Mayo Clinic proceedings.

[32]  J. Mccall,et al.  Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. , 1987, The Journal of biological chemistry.

[33]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.